SCHEMBL7963565

SCHEMBL7963565

N#C/C(=C\c1ccc(O)c(O)c1)S(=O)(=O)Cc1cccc(C(F)(F)F)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 11/20 0.53
▸ ERBB2 P04626 7/20 0.52
▸ KDM4E B2RXH2 6/20 0.50
▸ MEN1 O00255 6/20 0.50
▸ ALDH1A1 P00352 6/20 0.50
▸ HPGD P15428 6/20 0.50
▸ KMT2A Q03164 6/20 0.50
▸ HSD17B10 Q99714 6/20 0.50
▸ TDP1 Q9NUW8 6/20 0.50
▸ ALOX15 P16050 5/20 0.50
▸ ALOX12 P18054 5/20 0.50
▸ SMN1; SMN2 Q16637 5/20 0.50
▸ PKM P14618 3/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ POLB P06746 2/20 0.50
▸ GAA P10253 2/20 0.50
▸ ALPG P10696 1/20 0.50
▸ DNM1 Q05193 3/20 0.43
▸ TP53 P04637 5/20 0.41
▸ CYP1A2 P05177 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7963571 1.00 EGFR (0.53) EGFRERBB2KDM4EMEN1ALDH1A1
SCHEMBL7963573 1.00 EGFR (0.53) EGFRERBB2KDM4EMEN1ALDH1A1
SCHEMBL8321144 0.86 KMT2A (0.45) EGFRERBB2KDM4EMEN1ALDH1A1
SCHEMBL7952691 0.85 EGFR (0.55) EGFRERBB2KDM4EMEN1ALDH1A1
SCHEMBL7952695 0.85 EGFR (0.55) EGFRERBB2KDM4EMEN1ALDH1A1
SCHEMBL7952698 0.85 EGFR (0.55) EGFRERBB2KDM4EMEN1ALDH1A1
SCHEMBL7963391 0.84 LMNA (0.38) EGFRERBB2POLBGAAMAPT
SCHEMBL7963384 0.84 LMNA (0.38) EGFRERBB2POLBGAAMAPT
SCHEMBL7963389 0.84 LMNA (0.38) EGFRERBB2POLBGAAMAPT
SCHEMBL4185081 0.83 EGFR (0.56) EGFRERBB2KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 — — US claimed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 — — WO claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 — — US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 — — US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 — — US disclosed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 — — WO disclosed
Send feedback